Industry: Service & Software
Published Date: 2026-04-21
Pages: 105 Pages
Report ld: 6602256
Request Sample
Customized Report
Spatial Genomics & Transcriptomics Market Size(US$)

CAGR 2026-2032
6.2%
Market Size,2032
USD 333
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Spatial Genomics & Transcriptomics market was valued at US$ 220 million in 2025 and is anticipated to reach US$ 333 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
The North American market for Spatial Genomics & Transcriptomics is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Spatial Genomics & Transcriptomics is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Spatial Genomics & Transcriptomics in Academic Research is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Spatial Genomics & Transcriptomics include NanoString Technologies, Seven Bridges Genomic, Horizon Discovery Group, CARTANA, Advanced Cell Diagnostics, 10x Genomics, Dovetail Genomics, Illumina, S2 Genomics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Spatial Genomics & Transcriptomics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Spatial Genomics & Transcriptomics. The Spatial Genomics & Transcriptomics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Spatial Genomics & Transcriptomics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Spatial Genomics & Transcriptomics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Spatial Genomics & Transcriptomics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spatial Genomics & Transcriptomics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Instruments
1.2.3 Consumables
1.2.4 Software
1.3 Market by Application
1.3.1 Global Spatial Genomics & Transcriptomics Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Academic Research
1.3.3 Pharmaceutical Manufacturer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Spatial Genomics & Transcriptomics Market Perspective (2021–2032)
2.2 Global Spatial Genomics & Transcriptomics Growth Trends by Region
2.2.1 Global Spatial Genomics & Transcriptomics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Spatial Genomics & Transcriptomics Historic Market Size by Region (2021–2026)
2.2.3 Spatial Genomics & Transcriptomics Forecasted Market Size by Region (2027–2032)
2.3 Spatial Genomics & Transcriptomics Market Dynamics
2.3.1 Spatial Genomics & Transcriptomics Industry Trends
2.3.2 Spatial Genomics & Transcriptomics Market Drivers
2.3.3 Spatial Genomics & Transcriptomics Market Challenges
2.3.4 Spatial Genomics & Transcriptomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spatial Genomics & Transcriptomics Players by Revenue
3.1.1 Global Top Spatial Genomics & Transcriptomics Players by Revenue (2021–2026)
3.1.2 Global Spatial Genomics & Transcriptomics Revenue Market Share by Players (2021–2026)
3.2 Global Top Spatial Genomics & Transcriptomics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Spatial Genomics & Transcriptomics Revenue
3.4 Global Spatial Genomics & Transcriptomics Market Concentration Ratio
3.4.1 Global Spatial Genomics & Transcriptomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spatial Genomics & Transcriptomics Revenue in 2025
3.5 Global Key Players of Spatial Genomics & Transcriptomics Head Offices and Areas Served
3.6 Global Key Players of Spatial Genomics & Transcriptomics, Products and Applications
3.7 Global Key Players of Spatial Genomics & Transcriptomics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Spatial Genomics & Transcriptomics Breakdown Data by Type
4.1 Global Spatial Genomics & Transcriptomics Historic Market Size by Type (2021–2026)
4.2 Global Spatial Genomics & Transcriptomics Forecasted Market Size by Type (2027–2032)
5 Spatial Genomics & Transcriptomics Breakdown Data by Application
5.1 Global Spatial Genomics & Transcriptomics Historic Market Size by Application (2021–2026)
5.2 Global Spatial Genomics & Transcriptomics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Spatial Genomics & Transcriptomics Market Size (2021–2032)
6.2 North America Spatial Genomics & Transcriptomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Spatial Genomics & Transcriptomics Market Size by Country (2021–2026)
6.4 North America Spatial Genomics & Transcriptomics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Spatial Genomics & Transcriptomics Market Size (2021–2032)
7.2 Europe Spatial Genomics & Transcriptomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Spatial Genomics & Transcriptomics Market Size by Country (2021–2026)
7.4 Europe Spatial Genomics & Transcriptomics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Spatial Genomics & Transcriptomics Market Size (2021–2032)
8.2 Asia-Pacific Spatial Genomics & Transcriptomics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Spatial Genomics & Transcriptomics Market Size by Region (2021–2026)
8.4 Asia-Pacific Spatial Genomics & Transcriptomics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Spatial Genomics & Transcriptomics Market Size (2021–2032)
9.2 Latin America Spatial Genomics & Transcriptomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Spatial Genomics & Transcriptomics Market Size by Country (2021–2026)
9.4 Latin America Spatial Genomics & Transcriptomics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spatial Genomics & Transcriptomics Market Size (2021–2032)
10.2 Middle East & Africa Spatial Genomics & Transcriptomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Spatial Genomics & Transcriptomics Market Size by Country (2021–2026)
10.4 Middle East & Africa Spatial Genomics & Transcriptomics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NanoString Technologies
11.1.1 NanoString Technologies Company Details
11.1.2 NanoString Technologies Business Overview
11.1.3 NanoString Technologies Spatial Genomics & Transcriptomics Introduction
11.1.4 NanoString Technologies Revenue in Spatial Genomics & Transcriptomics Business (2021–2026)
11.1.5 NanoString Technologies Recent Development
11.2 Seven Bridges Genomic
11.2.1 Seven Bridges Genomic Company Details
11.2.2 Seven Bridges Genomic Business Overview
11.2.3 Seven Bridges Genomic Spatial Genomics & Transcriptomics Introduction
11.2.4 Seven Bridges Genomic Revenue in Spatial Genomics & Transcriptomics Business (2021–2026)
11.2.5 Seven Bridges Genomic Recent Development
11.3 Horizon Discovery Group
11.3.1 Horizon Discovery Group Company Details
11.3.2 Horizon Discovery Group Business Overview
11.3.3 Horizon Discovery Group Spatial Genomics & Transcriptomics Introduction
11.3.4 Horizon Discovery Group Revenue in Spatial Genomics & Transcriptomics Business (2021–2026)
11.3.5 Horizon Discovery Group Recent Development
11.4 CARTANA
11.4.1 CARTANA Company Details
11.4.2 CARTANA Business Overview
11.4.3 CARTANA Spatial Genomics & Transcriptomics Introduction
11.4.4 CARTANA Revenue in Spatial Genomics & Transcriptomics Business (2021–2026)
11.4.5 CARTANA Recent Development
11.5 Advanced Cell Diagnostics
11.5.1 Advanced Cell Diagnostics Company Details
11.5.2 Advanced Cell Diagnostics Business Overview
11.5.3 Advanced Cell Diagnostics Spatial Genomics & Transcriptomics Introduction
11.5.4 Advanced Cell Diagnostics Revenue in Spatial Genomics & Transcriptomics Business (2021–2026)
11.5.5 Advanced Cell Diagnostics Recent Development
11.6 10x Genomics
11.6.1 10x Genomics Company Details
11.6.2 10x Genomics Business Overview
11.6.3 10x Genomics Spatial Genomics & Transcriptomics Introduction
11.6.4 10x Genomics Revenue in Spatial Genomics & Transcriptomics Business (2021–2026)
11.6.5 10x Genomics Recent Development
11.7 Dovetail Genomics
11.7.1 Dovetail Genomics Company Details
11.7.2 Dovetail Genomics Business Overview
11.7.3 Dovetail Genomics Spatial Genomics & Transcriptomics Introduction
11.7.4 Dovetail Genomics Revenue in Spatial Genomics & Transcriptomics Business (2021–2026)
11.7.5 Dovetail Genomics Recent Development
11.8 Illumina
11.8.1 Illumina Company Details
11.8.2 Illumina Business Overview
11.8.3 Illumina Spatial Genomics & Transcriptomics Introduction
11.8.4 Illumina Revenue in Spatial Genomics & Transcriptomics Business (2021–2026)
11.8.5 Illumina Recent Development
11.9 S2 Genomics
11.9.1 S2 Genomics Company Details
11.9.2 S2 Genomics Business Overview
11.9.3 S2 Genomics Spatial Genomics & Transcriptomics Introduction
11.9.4 S2 Genomics Revenue in Spatial Genomics & Transcriptomics Business (2021–2026)
11.9.5 S2 Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Spatial Genomics & Transcriptomics was estimated to be worth US$ 220 million in 2025 and is projected to reach US$ 333 million, growing at a CAGR of 6.2% from 2026 to 2032.
Published Date: 2026-07-09
Pages: 103
USD 3950.00
(Single User License)
The global Spatial Genomics & Transcriptomics market is projected to grow from US$ 208 million in 2024 to US$ 315 million by 2031, at a CAGR of 6.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-25
Pages: 127
USD 4900.00
(Single User License)
The global Spatial Genomics & Transcriptomics market size was US$ 208 million in 2024 and is forecast to a readjusted size of US$ 315 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 76
USD 4250.00
(Single User License)
The global market for Spatial Genomics & Transcriptomics was estimated to be worth US$ 208 million in 2024 and is forecast to a readjusted size of US$ 315 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 90
USD 3950.00
(Single User License)
The global market for Spatial Genomics & Transcriptomics was valued at US$ 208 million in the year 2024 and is projected to reach a revised size of US$ 315 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Published Date: 2025-02-21
Pages: 74
USD 2900.00
(Single User License)
Market Analysis and Insights: Global Spatial Genomics & Transcriptomics Market
Published Date: 2024-04-06
Pages: 91
USD 4900.00
(Single User License)
The global Spatial Genomics & Transcriptomics market was valued at US$ 184.2 million in 2023 and is anticipated to reach US$ 282.9 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
Published Date: 2024-01-10
Pages: 73
USD 2900.00
(Single User License)
The global market for Spatial Genomics & Transcriptomics was estimated to be worth US$ 220 million in 2025 and is projected to reach US$ 333 million, growing at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-07-09
Pages: 103
The global Spatial Genomics & Transcriptomics market is projected to grow from US$ 208 million in 2024 to US$ 315 million by 2031, at a CAGR of 6.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-25
Pages: 127
The global Spatial Genomics & Transcriptomics market size was US$ 208 million in 2024 and is forecast to a readjusted size of US$ 315 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 76
The global market for Spatial Genomics & Transcriptomics was estimated to be worth US$ 208 million in 2024 and is forecast to a readjusted size of US$ 315 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 90
The global market for Spatial Genomics & Transcriptomics was valued at US$ 208 million in the year 2024 and is projected to reach a revised size of US$ 315 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Published: 2025-02-21
Pages: 74
Market Analysis and Insights: Global Spatial Genomics & Transcriptomics Market
Published: 2024-04-06
Pages: 91
The global Spatial Genomics & Transcriptomics market was valued at US$ 184.2 million in 2023 and is anticipated to reach US$ 282.9 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
Published: 2024-01-10
Pages: 73
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now